Triptan persistency among newly initiated users in a pharmacy claims database

Božena J. Katić, Srini Rajagopalan, Tony W. Ho, Ya Ting Chen, X. Henry Hu

Research output: Contribution to journalArticle

Abstract

Objective: Our study was conducted to describe prescription refill patterns among patients newly treated with triptans. Background: Although triptans are efficacious in treating migraine headache, the persistency of triptan use among newly initiated users has not been well described. Methods: From a US pharmacy claims database, we identified patients receiving new triptan monotherapy prescriptions from 2001 to 2005. Prescription refill information was gathered for two years for each patient. Persistency was defined as sustained refills of the index triptan prescription, regardless of duration between refills. Results: Of 40,892 patients receiving a new triptan prescription, 53.8% (N = 22031) did not persistently refill their index triptan. Of these, 25.5% discontinued prescription migraine therapy, 7.4% switched to a different triptan, and 67.1% switched to a non-triptan migraine medication at the time of their first refill. Only 46.2% of patients received at least one persistent refill. Conclusions: Migraine patients were more likely to discontinue their triptan after their index prescription than at any other time in their prescription refill history. The majority of patients did not persistently refill triptans, but filled prescriptions for non-specific migraine therapies such as opioids and non-steroidal anti-inflammatory drugs. Reasons for triptan discontinuation warrant further investigation.

Original languageEnglish (US)
Pages (from-to)488-500
Number of pages13
JournalCephalalgia
Volume31
Issue number4
DOIs
StatePublished - Apr 2011
Externally publishedYes

Fingerprint

Tryptamines
Prescriptions
Databases
Migraine Disorders
Opioid Analgesics
Anti-Inflammatory Agents

Keywords

  • claims data
  • migraine medication adherence
  • refill patterns
  • Triptan persistency

ASJC Scopus subject areas

  • Clinical Neurology
  • Medicine(all)

Cite this

Katić, B. J., Rajagopalan, S., Ho, T. W., Chen, Y. T., & Hu, X. H. (2011). Triptan persistency among newly initiated users in a pharmacy claims database. Cephalalgia, 31(4), 488-500. https://doi.org/10.1177/0333102410383058

Triptan persistency among newly initiated users in a pharmacy claims database. / Katić, Božena J.; Rajagopalan, Srini; Ho, Tony W.; Chen, Ya Ting; Hu, X. Henry.

In: Cephalalgia, Vol. 31, No. 4, 04.2011, p. 488-500.

Research output: Contribution to journalArticle

Katić, BJ, Rajagopalan, S, Ho, TW, Chen, YT & Hu, XH 2011, 'Triptan persistency among newly initiated users in a pharmacy claims database', Cephalalgia, vol. 31, no. 4, pp. 488-500. https://doi.org/10.1177/0333102410383058
Katić, Božena J. ; Rajagopalan, Srini ; Ho, Tony W. ; Chen, Ya Ting ; Hu, X. Henry. / Triptan persistency among newly initiated users in a pharmacy claims database. In: Cephalalgia. 2011 ; Vol. 31, No. 4. pp. 488-500.
@article{9b4a160c112148debcb7e0dd243b1772,
title = "Triptan persistency among newly initiated users in a pharmacy claims database",
abstract = "Objective: Our study was conducted to describe prescription refill patterns among patients newly treated with triptans. Background: Although triptans are efficacious in treating migraine headache, the persistency of triptan use among newly initiated users has not been well described. Methods: From a US pharmacy claims database, we identified patients receiving new triptan monotherapy prescriptions from 2001 to 2005. Prescription refill information was gathered for two years for each patient. Persistency was defined as sustained refills of the index triptan prescription, regardless of duration between refills. Results: Of 40,892 patients receiving a new triptan prescription, 53.8{\%} (N = 22031) did not persistently refill their index triptan. Of these, 25.5{\%} discontinued prescription migraine therapy, 7.4{\%} switched to a different triptan, and 67.1{\%} switched to a non-triptan migraine medication at the time of their first refill. Only 46.2{\%} of patients received at least one persistent refill. Conclusions: Migraine patients were more likely to discontinue their triptan after their index prescription than at any other time in their prescription refill history. The majority of patients did not persistently refill triptans, but filled prescriptions for non-specific migraine therapies such as opioids and non-steroidal anti-inflammatory drugs. Reasons for triptan discontinuation warrant further investigation.",
keywords = "claims data, migraine medication adherence, refill patterns, Triptan persistency",
author = "Katić, {Božena J.} and Srini Rajagopalan and Ho, {Tony W.} and Chen, {Ya Ting} and Hu, {X. Henry}",
year = "2011",
month = "4",
doi = "10.1177/0333102410383058",
language = "English (US)",
volume = "31",
pages = "488--500",
journal = "Cephalalgia",
issn = "0333-1024",
publisher = "SAGE Publications Ltd",
number = "4",

}

TY - JOUR

T1 - Triptan persistency among newly initiated users in a pharmacy claims database

AU - Katić, Božena J.

AU - Rajagopalan, Srini

AU - Ho, Tony W.

AU - Chen, Ya Ting

AU - Hu, X. Henry

PY - 2011/4

Y1 - 2011/4

N2 - Objective: Our study was conducted to describe prescription refill patterns among patients newly treated with triptans. Background: Although triptans are efficacious in treating migraine headache, the persistency of triptan use among newly initiated users has not been well described. Methods: From a US pharmacy claims database, we identified patients receiving new triptan monotherapy prescriptions from 2001 to 2005. Prescription refill information was gathered for two years for each patient. Persistency was defined as sustained refills of the index triptan prescription, regardless of duration between refills. Results: Of 40,892 patients receiving a new triptan prescription, 53.8% (N = 22031) did not persistently refill their index triptan. Of these, 25.5% discontinued prescription migraine therapy, 7.4% switched to a different triptan, and 67.1% switched to a non-triptan migraine medication at the time of their first refill. Only 46.2% of patients received at least one persistent refill. Conclusions: Migraine patients were more likely to discontinue their triptan after their index prescription than at any other time in their prescription refill history. The majority of patients did not persistently refill triptans, but filled prescriptions for non-specific migraine therapies such as opioids and non-steroidal anti-inflammatory drugs. Reasons for triptan discontinuation warrant further investigation.

AB - Objective: Our study was conducted to describe prescription refill patterns among patients newly treated with triptans. Background: Although triptans are efficacious in treating migraine headache, the persistency of triptan use among newly initiated users has not been well described. Methods: From a US pharmacy claims database, we identified patients receiving new triptan monotherapy prescriptions from 2001 to 2005. Prescription refill information was gathered for two years for each patient. Persistency was defined as sustained refills of the index triptan prescription, regardless of duration between refills. Results: Of 40,892 patients receiving a new triptan prescription, 53.8% (N = 22031) did not persistently refill their index triptan. Of these, 25.5% discontinued prescription migraine therapy, 7.4% switched to a different triptan, and 67.1% switched to a non-triptan migraine medication at the time of their first refill. Only 46.2% of patients received at least one persistent refill. Conclusions: Migraine patients were more likely to discontinue their triptan after their index prescription than at any other time in their prescription refill history. The majority of patients did not persistently refill triptans, but filled prescriptions for non-specific migraine therapies such as opioids and non-steroidal anti-inflammatory drugs. Reasons for triptan discontinuation warrant further investigation.

KW - claims data

KW - migraine medication adherence

KW - refill patterns

KW - Triptan persistency

UR - http://www.scopus.com/inward/record.url?scp=84862833181&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84862833181&partnerID=8YFLogxK

U2 - 10.1177/0333102410383058

DO - 10.1177/0333102410383058

M3 - Article

VL - 31

SP - 488

EP - 500

JO - Cephalalgia

JF - Cephalalgia

SN - 0333-1024

IS - 4

ER -